...
首页> 外文期刊>Journal of Functional Foods >Therapeutic potential and recent delivery systems of berberine: A wonder molecule
【24h】

Therapeutic potential and recent delivery systems of berberine: A wonder molecule

机译:小檗碱的治疗潜力和最近的递送系统:奇迹分子

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

Currently, phytoconstituents have been emerged as a scientific interest in discovering novel therapeutics against numerous diseases. Berberine is a bioactive alkaloid, historically reported for pharmacological actions such as diuretic, antidiarrheal, antimicrobial and antiprotozoal etc. Scientific evidences exhibit its versatile therapeutic uses against several metabolic, cardiac and neurologic disorders. Despite of valuable properties, the clinical use of berberine has been limited due to its poor intestinal absorption, low bioavailability and limited penetration. Therefore, it demands development of efficient delivery systems to overcome its limitations. This article not only focuses on mode of actions, physicochemical, pharmacokinetic and pharmacodynamic properties of berberine, but also highlights the attempt made so far to deliver it through conventional and novel formulations. Here, a structured division has been briefed, rendering conventional, lipid-based, polymeric-based and miscellaneous berberine formulation. Although extensive in-vitro and preclinical studies have been reported, commercial exploitation of berberine needs in-depth clinical safety and efficacy data.
机译:目前,植物组织被出现为对众多疾病的新疗法进行科学兴趣。 Berberine是一种生物活性生物碱,历史上报道了药物,抗病,抗菌和抗磷脂异常等药理作用等。科学证据表明其对几种代谢,心脏病和神经系统疾病的通用治疗用途。尽管属性有价值,但由于其肠道吸收,低生物利用度和有限的渗透而受到限制的临床应用。因此,它需要开发有效的交付系统来克服其限制。本文不仅重点侧重于小檗碱的作用,物理化学,药代动力学和药物动力学特性,但也强调了迄今为止通过常规和新配方递送它的尝试。这里,已经简述了一种结构化分裂,呈现常规,基于脂质,基于聚合物和杂种的Berberine制剂。虽然已经报道了广泛的体外和临床前研究,但梅伯琳的商业利用需要深入的临床安全性和疗效数据。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号